glp-1 employer healthcare costs Employers Grapple with Claims versus Outcomes of Drugs Weight loss drugs are hiking

For a 180-pound patient, that is roughly 100 to 130 grams of protein per day more than most patients are eating when appetite is suppressed

A microneedle-based smart patch sensor platform has been developed for painless and continuous glucose monitoring for patients with diabetes

Prolonged tension can create soreness, pressure, or pain

Newer medications are designed to activate both GLP-1 and GIP receptors at the same time, which may provide a stronger effect on appetite regulation and metabolic health

The momentum has only accelerated, contributing to the rising cost of treating diabetes

Improved Metabolic Health With tirzepatide, patients have noticed improvements in metabolic health indicators such as blood sugar levels, blood pressure, cholesterol profiles, and inflammation markers